Open

This study tests whether CT-155 improves negative symptoms associated with schizophrenia.

This study tests whether the investigational device CT-155 improves negative symptoms associated with schizophrenia.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Extended hours (M-F, early morning or evening)
Visits can be combined with regular clinical appointments

Location

North Carolina (Statewide)

What will be asked of you

At each visit, you will meet with a member of the study team (in-person or remote) to complete interviews and questionnaires. During the 16-week intervention period, the Study App will instruct you to access and perform tasks at about the same time every day via your personal smartphone. The study will also collect urine samples at each in-person visit.

Incentives

Compensation will be provided at the completion of each study visit via a prepaid VISA giftcard, gas reimbursement

In-person visits:
4

Phone or online visits:
3

Total length of participation:
5 months

Looking for Specific Volunteers

Able to participate:

Have a diagnosis of Schizophrenia
Outpatient, with no hospitalization for worsening schizophrenia in the past 3 months
Be on stable antipsychotic treatment, except for clozapine and haloperidol
s the sole user of an iPhone (iOS) 14 or greater, or a smartphone w/ an Android operating system (OS) 10 or greater
Has regular access to the Internet via cellular data plan and/or wi-fi.

Not eligible if:

Has participated in a CT-155 clinical study
Has a current diagnosis of substance or alcohol use disorder
Has participated in another clinical study (interventional or observational) in the last 6 months

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Medical School Wing B (UNC-Chapel Hill)
332 Emergency Room Dr, Chapel Hill, NC 27514, USA

Secondary Visit Location

North Carolina Psychiatric Research Center
401 East Whitaker Mill Road, Raleigh, NC, USA

Additional Study Information

Principal Investigator

Fred Jarskog
Psychiatry - General

Study Type

Clinical or Medical
Interventional

Study Topics

Behavior
Chronic Conditions
Mental and Emotional Health

IRB Number

23-0538

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.